Characterisation of fluoroquinolone-resistant clinical isolates of Streptococcus pyogenes in Barcelona, Spain

被引:18
|
作者
Rivera, A
Rebollo, M
Sánchez, F
Navarro, F
Miró, E
Mirelis, B
Coll, P
机构
[1] Hosp Santa Creu & Sant Pau, Microbiol Serv, Barcelona 08025, Spain
[2] Univ Autonoma Barcelona, Dept Genet & Microbiol, Unitat Microbiol, E-08193 Barcelona, Spain
关键词
epidemiology; gyrA; parC; quinolones; resistance; Streptococcus pyogenes;
D O I
10.1111/j.1469-0691.2005.01216.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Resistance mechanisms and clonal relationships were determined for six Streptococcus pyogenes isolates with low- or high-level ciprofloxacin resistance. Four isolates displayed reduced susceptibility to ciprofloxacin and levofloxacin and had alterations in ParC: Ser80 -> Pro (isolate emm3.1); Ser79 -> Ala (two isolates emm6.0); and a double substitution Ser79 -> Phe and Ala121 -> Val (isolate emm12.27). Two isolates (emm12.26) displayed high-level resistance to ciprofloxacin and levofloxacin, as well as to other quinolones. These isolates had the same double substitution in ParC as isolate emm12.27, and an additional substitution (Ser81 -> Tyr) in GyrA. Resistance patterns, emm typing and sequencing of the quinolone resistance-determining regions defined two clusters containing three and two isolates, respectively.
引用
下载
收藏
页码:759 / 761
页数:3
相关论文
共 50 条
  • [31] Cross-resistance, relatedness and allele analysis of fluoroquinolone-resistant US clinical isolates of Streptococcus pneumoniae (1998-2000)
    Davies, TA
    Goldschmidt, R
    Pfleger, S
    Loeloff, M
    Bush, K
    Sahm, DF
    Evangelista, A
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (02) : 168 - 175
  • [32] Clinical isolates of macrolide-resistant Streptococcus pyogenes in Central Greece
    Petinaki, E
    Kontos, F
    Pratti, A
    Skulakis, C
    Maniatis, AN
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2003, 21 (01) : 67 - 70
  • [33] Molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates from Shanghai, China
    Zhu, Cuiyun
    Zhang, Yongxin
    Shen, Yinzhong
    Siu, Gilman Kit Hang
    Wu, Wenjuan
    Qian, Xueqin
    Deng, Guilin
    Xu, Yan
    Lau, Ricky
    Fan, Xiaoyong
    Zhang, Wenhong
    Lu, Hongzhou
    Yam, Wing-Cheong
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2012, 73 (03) : 260 - 263
  • [34] High Proportion of Heteroresistance in gyrA and gyrB in Fluoroquinolone-Resistant Mycobacterium tuberculosis Clinical Isolates
    Eilertson, Brandon
    Maruri, Fernanda
    Blackman, Amondrea
    Herrera, Miguel
    Samuels, David C.
    Sterling, Timothy R.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (06) : 3270 - 3275
  • [35] Characterisation of unusual patterns of MLS resistance among Streptococcus pyogenes clinical isolates
    Vitali, L.
    Rombini, S.
    Petrelli, D.
    D'Ercole, S.
    Pasquantonio, G.
    Ripa, C.
    Prenna, M.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S613 - S613
  • [36] Persistence and Complex Evolution of Fluoroquinolone-Resistant Streptococcus pneumoniae Clone
    Ben-David, Debby
    Schwaber, Mitchell J.
    Adler, Amos
    Masarwa, Samira
    Edgar, Rotem
    Navon-Venezia, Shiri
    Schwartz, David
    Porat, Nurith
    Kotlovsky, Tali
    Polivkin, Nikolay
    Weinberg, Irina
    Lazary, Avraham
    Ohana, Nissim
    Dagan, Ron
    EMERGING INFECTIOUS DISEASES, 2014, 20 (05) : 799 - 805
  • [37] Distribution of CRISPR Types in Fluoroquinolone-Resistant Campylobacter jejuni Isolates
    Adiguzel, Mehmet Cemal
    Goulart, Debora Brito
    Wu, Zuowei
    Pang, Jinji
    Cengiz, Seyda
    Zhang, Qijing
    Sahin, Orhan
    PATHOGENS, 2021, 10 (03):
  • [38] gyrA mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coli
    Conrad, S
    Oethinger, M
    Kaifel, K
    Klotz, G
    Marre, R
    Kern, WV
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (03) : 443 - 455
  • [39] Antimicrobial activity of gemifloxacin (SB-265805), a newer fluoroquinolone, against clinical isolates of Neisseria gonorrhoeae, including fluoroquinolone-resistant isolates
    Tanaka, M
    Tunoe, H
    Mochida, O
    Kanayama, A
    Saika, T
    Kobayashi, I
    Naito, S
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2000, 38 (02) : 109 - 113
  • [40] Characterization of Recombinant Fluoroquinolone-Resistant Pneumococcus-Like Isolates
    Balsalobre, Luz
    Ortega, Montserrat
    de la Campa, Adela G.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (01) : 254 - 260